These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23443317)

  • 1. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
    Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
    Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
    Zhang X; Zou G; Li X; Wang L; Xie T; Zhao J; Wang L; Jiao S; Xiang R; Ye H; Shi Y
    Cancer Biol Med; 2020 Aug; 17(3):693-706. PubMed ID: 32944400
    [No Abstract]   [Full Text] [Related]  

  • 4. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers.
    Murata T; Mizushima H; Chinen I; Moribe H; Yagi S; Hoffman RM; Kimura T; Yoshino K; Ueda Y; Enomoto T; Mekada E
    Cancer Res; 2011 Nov; 71(21):6633-42. PubMed ID: 22009535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.
    Koshikawa N; Mizushima H; Minegishi T; Iwamoto R; Mekada E; Seiki M
    Cancer Res; 2010 Jul; 70(14):6093-103. PubMed ID: 20587521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
    Benatar T; Yang W; Amemiya Y; Evdokimova V; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2012 Jun; 133(2):563-73. PubMed ID: 21997538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer.
    Miyata K; Yotsumoto F; Nam SO; Kuroki M; Miyamoto S
    Anticancer Res; 2012 Jun; 32(6):2347-52. PubMed ID: 22641673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
    Zou G; Zhang X; Wang L; Li X; Xie T; Zhao J; Yan J; Wang L; Ye H; Jiao S; Xiang R; Shi Y
    Theranostics; 2020; 10(15):6839-6853. PubMed ID: 32550907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease.
    Hollborn M; Iandiev I; Seifert M; Schnurrbusch UE; Wolf S; Wiedemann P; Bringmann A; Kohen L
    Curr Eye Res; 2006 Oct; 31(10):863-74. PubMed ID: 17050278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.
    Nishikawa K; Asai T; Shigematsu H; Shimizu K; Kato H; Asano Y; Takashima S; Mekada E; Oku N; Minamino T
    J Control Release; 2012 Jun; 160(2):274-80. PubMed ID: 22020380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo.
    Chen Z; Ruan Q; Han S; Xi L; Jiang W; Jiang H; Ostrov DA; Cai J
    Breast Cancer Res Treat; 2014 May; 145(1):45-59. PubMed ID: 24710637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.
    Di Mauro C; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Formisano L; De Falco S; Cicatiello V; Di Bonito M; Cantile M; Collina F; Chambery A; Veneziani BM; De Placido S; Bianco R
    Br J Cancer; 2017 May; 116(11):1425-1435. PubMed ID: 28441382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropomodulin 1 expression driven by NF-κB enhances breast cancer growth.
    Ito-Kureha T; Koshikawa N; Yamamoto M; Semba K; Yamaguchi N; Yamamoto T; Seiki M; Inoue J
    Cancer Res; 2015 Jan; 75(1):62-72. PubMed ID: 25398440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
    Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer.
    Yotsumoto F; Oki E; Tokunaga E; Maehara Y; Kuroki M; Miyamoto S
    Int J Cancer; 2010 Dec; 127(11):2707-17. PubMed ID: 20499311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2.
    Pan T; Zhou D; Shi Z; Qiu Y; Zhou G; Liu J; Yang Q; Cao L; Zhang J
    Cancer Lett; 2020 Jul; 482():102-111. PubMed ID: 31705927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.